POLYMYOSITIS

This study tested an experimental drug called KZR-616 in 25 adults with active polymyositis or dermatomyositis, two rare diseases that cause muscle inflammation and weakness. Participants received weekly injections of the drug or a placebo for 16 weeks, then switched to the other…

This study looked at the long-term safety and effectiveness of an experimental drug called KZR-616 in people with active polymyositis or dermatomyositis, two rare diseases that cause muscle inflammation and weakness. The 18 participants had already completed a previous study and …

This study looked at whether a whole-body MRI can correctly identify inflammatory muscle diseases like myositis. Researchers tested 139 people with suspected myositis to see how well MRI results matched the standard diagnosis from a muscle biopsy. The goal is to find a faster, le…

This study tested whether a personalized exercise program could improve daily function and quality of life for people with polymyositis or dermatomyositis, two rare diseases that cause muscle inflammation and weakness. Eighty adults with stable muscle problems took part. Research…

This study looked at a simple test called the Myositis Functional Index-3 (FI-3) to see if it can accurately measure muscle function in people with inflammatory myopathies (like dermatomyositis and polymyositis). Researchers compared it to advanced machines and also tested if rep…

This study looked at what causes autoimmune diseases that affect muscles and connective tissues, like myositis. Researchers collected blood samples and health information from 719 people, including patients, their relatives, and healthy volunteers. The goal was to find genetic an…